The emergence of new respiratory viruses such as swine flu strain (H1N2), avian influenza H5N1 and evolving COVID-19 variants reveal the urgent need for broad-spectrum antivirals. Existing ones like adamantane and nirmatrelvir target specific strains only. To address this, researchers are using artificial intelligence to find similarities between viruses like SARS-CoV-2, influenza and RSV to develop drugs with broad antiviral activity. Wider antiviral treatment could also combat non-respiratory viruses like Ebola and Enterovirus D68.
Group-IB’s Threat Intelligence and Defence Centre Equip Undergraduates with Sophisticated Cybersecurity Technologies to Boost Threat Analysis and Enhance Cyber Resilience for Campus Start-ups
Hey there from the heart of the San Francisco Bay Area! It’s an absolute pleasure to have you back again for our chat on some
